ClinicalTrials.Veeva

Menu

Analysis of Oxidative Stress Biomarkers and Their Determinants in ART-experienced PLWH (4477)

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

HIV Infections

Treatments

Other: blood sampling

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The project aims to assess the level of oxidative stress biomarkers in HIV patients on effective antiretroviral treatment in correlation with other therapeutic, clinical, and viro- immunological parameters. The analysis aims to better characterize the patient on treatment through an innovative approach based on two specific tests for complementary assessment of total oxidant and anti-oxidant plasma capacity.

Enrollment

543 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ART-treated PLWH
  • HIV-1 RNA< 50 copies/mL
  • Stable ART therapy (at least 48 weeks)
  • Signature of informed consent for study participation

Exclusion criteria

  • none

Trial design

543 participants in 1 patient group

Single arm
Description:
ART-experienced PLWH
Treatment:
Other: blood sampling

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems